Center-Authored Papers

Filters: Author is Saber, Wael  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
U
de Witte T, Bowen D, Robin M, Malcovati L, Niederwieser D, Yakoub-Agha I, Mufti GJ, Fenaux P, Sanz G, Martino R et al..  2017.  Use of hematopoietic cell transplantation for patients with myelodysplastic syndrome and chronic myelomonocytic leukemia.. Blood.
S
Ringdén O, Brazauskas R, Wang Z, Ahmed I, Atsuta Y, Buchbinder D, Burns LJ, Cahn J-Y, Duncan C, Hale GA et al..  2014.  Second solid cancers after allogeneic hematopoietic cell transplantation using reduced intensity conditioning.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. Abstract
Michaelis LC, Saad A, Zhong X, Le-Rademacher J, Freytes CO, Marks DI, Lazarus HM, Bird JM, Holmberg L, Kamble RT et al..  2013.  Salvage Second Hematopoietic Cell Transplantation in Myeloma.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. Abstract
R
Rosko A, Wang H-L, DeLima M, Sandmaier B, Khoury JH, Artz A, Brammer J, Bredeson C, Farag S, Kharfan-Dabaja M et al..  2016.  Reduced Intensity Conditioned Allograft Yields Favorable Survival for Older Adults with B-cell Acute Lymphoblastic Leukemia.. American journal of hematology. Abstract
P
Lindsley CR, Saber W, Mar BG, Redd R, Wang T, Haagenson MD, Grauman PV, Hu Z-H, Spellman SR, Lee SJ et al..  2017.  Prognostic Mutations in Myelodysplastic Syndrome after Stem-Cell Transplantation.. The New England journal of medicine. 376(6):536-547. Abstract
Seftel MD, Neuberg D, Zhang M-J, Wang H-L, Ballen KK, Bergeron J, Couban S, Freytes CO, Hamadani M, Kharfan-Dabaja MA et al..  2016.  Pediatric-inspired therapy compared to allografting for Philadelphia chromosome-negative adult ALL in first complete remission.. American journal of hematology. 91(3):322-329. Abstract
N
Mahindra A, Raval G, Mehta P, Brazauskas R, Zhang M-J, Zhong X, Bird JM, Freytes CO, Hale GA, Herzig R et al..  2015.  New cancers after autotransplantations for multiple myeloma.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 21(4):738-45. Abstract
Morton LM, Saber W, Baker KS, Barrett JA, Bhatia S, Engels EA, Gadalla SM, Kleiner DE, Pavletic S, Burns LJ.  2016.  National Institutes of Health Hematopoietic Cell Transplantation Late Effects Initiative: Consensus Recommendations for Subsequent Neoplasms.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. Abstract
M
Saber W, Le Rademacher J, Sekeres M, Logan B, Lewis M, Mendizabal A, Leifer E, Appelbaum FR, Horowitz MM, Nakamura R et al..  2014.  Multi-Center Biologic Assignment Trial Comparing Reduced Intensity Allogeneic Hematopoietic Cell Transplant to Hypomethylating Therapy or Best Supportive Care in Patients Aged 50-75 with Intermediate-2 and High Risk Myelodysplastic Syndrome Blood and Marr. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. Abstract
I
Majhail NS, Farnia SH, Carpenter PA, Champlin RE, Crawford S, Marks DI, Omel JL, Orchard PJ, Palmer J, Saber W et al..  2015.  Indications for Autologous and Allogeneic Hematopoietic Cell Transplantation: Guidelines from the American Society for Blood and Marrow Transplantation.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. Abstract
Arai S, Arora M, Wang T, Spellman SR, He W, Couriel DR, Urbano-Ispizua A, Cutler CS, Bacigalupo AA, Battiwalla M et al..  2015.  Increasing incidence of chronic graft-versus-host disease in allogeneic transplantation: a report from the Center for International Blood and Marrow Transplant Research.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 21(2):266-74. Abstract
Hamadani M, Saber W, Woo Ahn K, Carreras J, Cairo MS, Fenske TS, Gale RP, Gibson J, Hale GA, Hari PN et al..  2013.  Impact of Pretransplant Conditioning Regimens on Outcomes of Allogeneic Transplantation for Chemotherapy-Unresponsive Diffuse Large B Cell Lymphoma and Grade III Follicular Lymphoma.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. Abstract
El-Jawahri A, Chen Y-B, Brazauskas R, He N, Lee SJ, Knight JM, Majhail N, Buchbinder D, Schears RM, Wirk BM et al..  2017.  Impact of pre-transplant depression on outcomes of allogeneic and autologous hematopoietic stem cell transplantation.. Cancer. Abstract
Hurley CK, Woolfrey A, Wang T, Haagenson M, Umejiego J, Aljurf M, Askar M, Battiwalla M, Dehn J, Horan J et al..  2013.  The impact of HLA unidirectional mismatches on the outcome of myeloablative hematopoietic stem cell transplantation with unrelated donors.. Blood. 121(23):4800-6. Abstract
Urbano-Ispizua A, Pavletic SZ, Flowers ME, Klein JP, Zhang M-J, Carreras J, Montoto S, Perales M-A, Aljurf MD, Akpek G et al..  2015.  The Impact of Graft Versus Host Disease on Relapse Rate in Patients with Lymphoma Depends on the Histological Sub-Type and the Intensity of the Conditioning Regimen.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. Abstract
H
Verneris MR, Lee SJ, Woo Ahn K, Wang H-L, Battiwalla M, Inamoto Y, Fernandez-Vina MA, Gajewski J, Pidala J, Munker R et al..  2015.  HLA-Mismatch Is Associated With Worse Outcomes After Unrelated Donor Reduced Intensity Conditioning Hematopoietic Cell Transplantation: An Analysis From The CIBMTR.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. Abstract
Deeg HJ, Bredeson C, Farnia S, Ballen K, Gupta V, Mesa RA, Popat U, Saber W, Seftel M, Tamari R et al..  2015.  Hematopoietic Cell Transplantation as Curative Therapy for Patients with Myelofibrosis: Long-Term Success in all Age Groups.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 21(11):1883-1887. Abstract
Saad A, Mahindra A, Zhang M-J, Zhong X, Costa LJ, Dispenzieri A, Drobyski WR, Freytes CO, Gale RP, Gasparetto CJ et al..  2013.  Hematopoietic Cell Transplant Comorbidity Index Is Predictive of Survival after Autologous Hematopoietic Cell Transplantation in Multiple Myeloma.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. Abstract
E
Hamadani M, Hari PN, Zhang Y, Carreras J, Akpek G, Aljurf MD, Ayala E, Bachanova V, Chen AI, Chen Y-B et al..  2014.  Early Failure of Frontline Rituximab-containing Chemoimmunotherapy in Diffuse Large B-Cell Lymphoma does not Predict Futility of Autologous Hematopoietic Cell Transplantation.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. Abstract
Teira P, Battiwalla M, Ramanathan M, Barrett JA, Woo Ahn K, Chen M, Green JS, Saad A, Antin JH, Savani BN et al..  2016.  Early cytomegalovirus reactivation remains associated with increased transplant-related mortality in the current era: a CIBMTR analysis.. Blood. 127(20):2427-2438. Abstract
D
Kim HT, Zhang M-J, Woolfrey AE, St Martin A, Chen J, Saber W, Perales M-A, Armand P, Eapen M.  2016.  Donor and recipient sex in allogeneic stem cell transplantation: what really matters.. Haematologica. Abstract
Sabloff M, Sobecks RM, Woo Ahn K, Zhu X, DeLima M, Brown JR, Inamoto Y, Holland KH, Aljurf MD, Laughlin MJ et al..  2014.  Does total body irradiation conditioning improve outcomes of myeloablative human leukocyte antigen-identical sibling transplantations for chronic lymphocytic leukemia? Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 20(3):421-4. Abstract
Deol A, Sengsayadeth S, Woo Ahn K, Wang H-L, Aljurf M, Antin JH, Battiwalla M, Bornhauser M, Cahn J-Y, Camitta B et al..  2016.  Does FLT3 mutation impact survival after hematopoietic stem cell transplantation for acute myeloid leukemia? A Center for International Blood and Marrow Transplant Research (CIBMTR) analysis. Cancer. Abstract
C
Michelis FV, Gupta V, Zhang M-J, Wang H-L, Aljurf M, Bacher U, Beitinjaneh A, Chen Y-B, DeFilipp Z, Gale RP et al..  2017.  Cytogenetic risk determines outcomes after allogeneic transplantation in older patients with acute myeloid leukemia in their second complete remission: A Center for International Blood and Marrow Transplant Research cohort analysis.. Cancer. Abstract
Ustun C, Gotlib J, Popat U, Artz A, Litzow M, Reiter A, Nakamura R, Kluin-Nelemans HC, Verstovsek S, Gajewski J et al..  2016.  Consensus Opinion on Allogeneic Hematopoietic Cell Transplantation in Advanced Systemic Mastocytosis.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 22(8):1348-1356. Abstract